GLP-class agonists and metabolic-signalling compounds — from semaglutide to the tri-agonist.
The most-cited pathway in current metabolic research, stocked as a ladder: semaglutide (GLP-1), GLP-2 TZ (GIP / GLP-1 dual) and GLP-3 R (GLP-1 / GIP / glucagon triple), plus the compounds studied alongside them — cagrilintide, 5-amino-1MQ, AOD-9604, tesamorelin and SLU-PP-332 in capsules.
Lab testedGLP-1 / GIP / glucagon triple agonist — the newest receptor profile on the shelf.
Lab testedGIP / GLP-1 dual agonist, stocked from 10 to 60 mg.
The GLP-1 agonist the whole category is measured against.
Long-acting amylin analog, developed to be studied beside a GLP-1 agonist.
Lab testedSmall-molecule NNMT inhibitor — adipocyte metabolism and NAD+ salvage research.
hGH fragment 176-191 — the lipolysis literature.
Lab testedGHRH analog studied in GH-axis and body-composition research.
Pan-ERR agonist in oral capsules — the exercise-mimetic literature.
Which compounds appear together in the published work on this shelf, and which of those we supply pre-blended at a printed ratio. Descriptions of the literature, not instructions — every product is supplied for laboratory research use only.
Cagrilintide was developed to be studied beside a GLP-1 agonist, and the semaglutide-plus-cagrilintide combination has become its own body of literature in satiety and body-composition research.
The three receptor profiles the field moved through, in order: GLP-1 alone, GIP / GLP-1, then GLP-1 / GIP / glucagon. Stocking all three lets a comparison run on matched, certified lots.
Two routes into the body-composition literature that do not touch the incretin receptors at all — a GHRH analog studied on the GH axis and the 176-191 fragment of hGH studied in lipolysis.
Selank, Semax and DSIP — as lyophilised vials and pre-mixed nasal sprays.
GLP-class agonists and metabolic-signalling compounds — from semaglutide to the tri-agonist.
BPC-157, TB-500, KPV, glutathione — and the BPC-157 + TB-500 blend at a printed ratio.
GH secretagogues, GHRH analogs and a long-acting IGF-1 — the signal, not the hormone.
NAD+, epithalon and the mitochondrial peptides MOTS-c and SS-31.
GHK-Cu, the Glow and Klow blends, and the melanocortin agonists MT-2 and PT-141.
Everything on this page is supplied strictly for laboratory research. These compounds are not drugs, foods, cosmetics or medical devices, are not for human or veterinary consumption or administration, and are not intended to diagnose, treat, cure or prevent any disease. Purchasing requires confirmation that you are 21 or older and a qualified researcher.
Statements here describe the compounds and the published literature concerning them — not outcomes in any person — and nothing on this page is medical advice. Purity figures are determined by HPLC with mass-spectrometric confirmation and apply to the lot identified on its certificate.
Restocks & new lots
A new lot, a new certificate, a new format. Nothing else, ever.
